Your session is about to expire
← Back to Search
Enhanced Case Management for Mental Health and Substance Use Disorders (TeachMeToBuild Trial)
N/A
Waitlist Available
Led By Giulio DiDiodato, MD PhD
Research Sponsored by Royal Victoria Hospital, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks post-program completion
Awards & highlights
No Placebo-Only Group
Summary
This trial will help NEET youth develop career skills and find long-term employment by identifying and addressing mental health and substance use issues.
Who is the study for?
This trial is for young adults who are not in employment, education, or training (NEET), specifically visible minorities or females with mental health and substance use issues. Participants must have Wi-Fi access, a computing device, speak English or French, and possess an Ontario Health Insurance Plan number and Canadian Social Insurance Number.
What is being tested?
The study tests if adding a daily self-reporting tool for distress and rapid access to mental health services improves the completion rates of vocational training programs for NEET youth at risk due to mental health/substance abuse.
What are the potential side effects?
There may be no direct medical side effects from participating in this trial as it involves case management interventions rather than medications. However, participants might experience stress or emotional discomfort when discussing personal issues.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 weeks post-program completion
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks post-program completion
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Post-program employment
Program attendance
Program completion
Secondary study objectives
Acceptability of self-report distress tool
Access to healthcare services
Apprentice satisfaction
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Basic case management supplemented by self-reporting distress tool (DT)Experimental Treatment1 Intervention
Basic case management plus access to the self-report daily distress tool. The trainees are provided web-based access to the daily distress tool and report their distress levels using a validated visual analog scale (Distress Thermometer), along with reporting their risk of missing work/class or dropping out of the program. The case manager responds to the distress tool by coordinating external support services as needed.
Group II: Basic case management supplemented by rapid access healthcare servicesExperimental Treatment1 Intervention
Basic case management supplemented by a fit-for-purpose rapid referral process for trainees with active mental health and/or substance use disorders affecting their program participation.
Group III: Basic case management supplemented by DT and rapid access healthcare servicesExperimental Treatment1 Intervention
Basic case management supplemented by both the self-report distress tool and rapid referral process for those trainees at-risk of program absence or drop-out from either mental health or addictions issues.
Group IV: Basic case managementActive Control1 Intervention
Basic case management with bi-weekly meetings between case manager and trainees that includes check-ins, frequent visits to construction sites and monitoring of feedback forms from mentors. Case managers attempt to connect trainees with external support services as needed.
Find a Location
Who is running the clinical trial?
Royal Victoria Hospital, CanadaLead Sponsor
17 Previous Clinical Trials
10,017 Total Patients Enrolled
Giulio DiDiodato, MD PhDPrincipal InvestigatorRoyal Victoria Regional Health Centre
1 Previous Clinical Trials
1,200 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a visible minority or female.I am fluent in English or French.Not applicable.
Research Study Groups:
This trial has the following groups:- Group 1: Basic case management supplemented by rapid access healthcare services
- Group 2: Basic case management supplemented by DT and rapid access healthcare services
- Group 3: Basic case management
- Group 4: Basic case management supplemented by self-reporting distress tool (DT)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.